These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

108 related items for PubMed ID: 5140007

  • 21. [Synthetic inhibitors of serine proteinases. 35. Inhibition action of amidino- and guanidinophenyl derivatives against hemolysis initiated by complement activation].
    Hoffmann A, Markwardt F.
    Pharmazie; 1989 Feb; 44(2):141-4. PubMed ID: 2748697
    [Abstract] [Full Text] [Related]

  • 22. Irreversible enzyme inhibitors. CLVI. Proteolytic enzymes. XII. Inhibitors of guinea pig complement derived by quaternization of 3-acylamidopyridines with alpha-bromomethylbenzenesulfonyl fluorides.
    Baker BR, Hurlbut JA.
    J Med Chem; 1969 Jul; 12(4):677-80. PubMed ID: 5815693
    [No Abstract] [Full Text] [Related]

  • 23. Interaction of the B-determinant of the third component of complement with amidino compounds.
    Asghar SS, Cormane RH.
    Immunochemistry; 1976 Dec; 13(12):975-8. PubMed ID: 65321
    [No Abstract] [Full Text] [Related]

  • 24. Irreversible enzyme inhibitors. CLXI. Proteolytic enzymes. 13. Inhibitors of guinea pig complement derived by quaternization of 3-acylamidopyridines with alpha-bromomethylbenzenesulfonyl fluorides. II.
    Baker BR, Hurlbut JA.
    J Med Chem; 1969 Sep; 12(5):902-5. PubMed ID: 5812209
    [No Abstract] [Full Text] [Related]

  • 25. Cyclic amidine analogues of taurine and homotaurine: synthesis and effects on rat skeletal muscle.
    Campagna F, Carotti A, Casini G, Palluotto F, Pierno S, Tricarico D, De Luca A, Conte-Camerino D.
    Farmaco; 1994 Oct; 49(10):653-8. PubMed ID: 7826472
    [Abstract] [Full Text] [Related]

  • 26. Irreversible enzyme inhibitors. CLII. Proteolytic enzymes. X. Inhibition of guinea pig complement by substituted benzamidines.
    Baker BR, Erickson EH.
    J Med Chem; 1969 May; 12(3):408-14. PubMed ID: 5788155
    [No Abstract] [Full Text] [Related]

  • 27. Irreversible enzyme inhibitors. CXIV. Proteolytic enzymes. IV. Additional active-site-directed irreversible inhibitors of alpha-chymotrypsin derived from phenoxyacetamides bearing a terminal sulfonyl fluoride.
    Baker BR, Hurlbut JA.
    J Med Chem; 1968 Mar; 11(2):241-5. PubMed ID: 5654209
    [No Abstract] [Full Text] [Related]

  • 28. Irreversible enzyme inhibitors. CXIX. Active-site-directed irreversible inhibitors of dihydrofolic reductase with tissue specificity derived from 2,4,6-triaminopyrimidine with a terminal sulfonyl fluoride at the 5 position.
    Baker BR, Meyer RB.
    J Med Chem; 1968 May; 11(3):489-94. PubMed ID: 5241408
    [No Abstract] [Full Text] [Related]

  • 29. Immune hemolysis: serial studies of the dissociability of IgG and IgM anti-Forssman antibodies using the C'la fixation and transfer technique.
    Linscott WD.
    J Immunol; 1969 Apr; 102(4):986-92. PubMed ID: 5768199
    [No Abstract] [Full Text] [Related]

  • 30. Novel bis(benzamidino) compounds with an aromatic central link. Inhibitors of thrombin, pancreatic kallikrein, trypsin, and complement.
    Geratz JD, Cheng MC, Tidwell RR.
    J Med Chem; 1976 May; 19(5):634-9. PubMed ID: 1271404
    [Abstract] [Full Text] [Related]

  • 31.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 32.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 33. Irreversible enzyme inhibitors. CXLII. Further studies on active-site-directed irreversible inhibitors of dihydrofolic reductase derived from 5-(p-Aminophenoxypropyl)-2,4,6-triaminopyrimidine bearing a terminal sulfonyl fluoride.
    Baker BR, Meyer RB.
    J Med Chem; 1969 Jan; 12(1):104-7. PubMed ID: 5763003
    [No Abstract] [Full Text] [Related]

  • 34. Irreversible enzyme inhibitors. CXII. Active-site-directed irreversible inhibitors of dihydrofolic reductase derived from 4,6-diamino-1,2-dihydro-2,2-dimethyl-1-phenyl-s-triazine substituted with a terminal sulfonyl fluoride. II.
    Baker BR, Lourens GJ.
    J Med Chem; 1968 Jan; 11(1):38-41. PubMed ID: 5237173
    [No Abstract] [Full Text] [Related]

  • 35.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 36. Synthesis and SAR of sulfonyl- and phosphoryl amidine compounds as anti-resorptive agents.
    Lee MY, Kim MH, Kim J, Kim SH, Kim BT, Jeong IH, Chang S, Kim SH, Chang SY.
    Bioorg Med Chem Lett; 2010 Jan 15; 20(2):541-5. PubMed ID: 20005100
    [Abstract] [Full Text] [Related]

  • 37.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 38.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 39. [Synthetic inhibitors of serine proteinases. 31. The inhibition of trypsin, plasmin and thrombin by isomeric compounds of N alpha -arylsulfonylated omega-amidinophenyl-alpha-aminoalkylcarboxylic acid amides].
    Stürzebecher J, Markwardt F, Vieweg H, Wagner G, Walsmann P.
    Pharmazie; 1984 Jun 15; 39(6):411-3. PubMed ID: 6237371
    [Abstract] [Full Text] [Related]

  • 40. Irreversible enzyme inhibitors. 113. Proteolytic enzymes. 3. Active-site-directed irreversible inhibitors of alpha-chymotrypsin derived from phenoxyacetamides with an N-fluorosulfonylphenyl substituent.
    Baker BR, Hurlbut JA.
    J Med Chem; 1968 Mar 15; 11(2):233-41. PubMed ID: 5654208
    [No Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 6.